Aumed, a.s., Komořanská 326/63, 143 14 Praha - Modřany, Česká republika

+420 603 587 701 English

AUMED, a.s. received a grant for the Innovation Project entitled “TFI Transfer Factor – Medicine”

TFI nova dotace

AUMED, a.s. received a grant in the Operational Program Enterprise and Innovation for Competitiveness under the Innovation Call – Innovation Project – Call VIII for a project entitled “TFI Transfer Factor – Medicine”, registration number CZ.01.1.02 / 0.0 / 0.0 / 20_318 / 0026008. The main purpose of this grant is to strengthen the company’s innovative performance and increase market competitiveness.

The aim and intention of the project is to create a new production and control center of AUMED, a.s., which will use the results of its own R&D for the production of an innovated preparation based on the transfer factor (TFI). The innovative immunomodulator will be fully competitive on the world markets.

The project is part of the long-term business concept and strategy of AUMED, a.s.. The project is focused on the production application of development results; specifically for the introduction of a new product (TFI) into standard production.

MORE ARTICLES

AUMED, a.s. successfully completed the 1st stage of the project entitled “Transferfaktor TFI – Medicinal product”

29. 11. 2022

AUMED, a.s. successfully completed the 1st stage of the project entitled “Transferfaktor TFI – Medicinal product”, registration number CZ.01.1.02/0.0/0.0/20_318/0026008. As…

AUMED, a.s. presented phage research at the Phages 2022 conference in Oxford

26. 09. 2022

AUMED participated in the 12th annual bacteriophage conference in Oxford, which is the only European phage conference with such a…

AUMED a.s. founded a new company AUMED Immunology a.s.

19. 09. 2022

AUMED a.s. founded a new company AUMED Immunology a.s.. AUMED, a.s. is the sole shareholder of the newly formed company….

Research projects of Aumed, a.s. are financed by the European Structural Funds:
Research and development of a new pertussis vaccine
Transfer factor — research and development of a new medical form
Production of diagnostic kit for covid-19 on the lamp principle
TFI Transfer Factor – Medicine

and with financial support from the state budget through the Ministry of Industry and Trade in the TRIO program:
Research and development of a new oral administration of vaccine

European Union
European Regional Development Fund
OP Enterprise and Innovation for Competitiveness


Tel.: +420 603 587 701
Komořanská 326/63, 143 14 Praha - Modřany, Česká republika
(c) 2017, Aumed a.s